212 related articles for article (PubMed ID: 32927795)
1. Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice.
Roda AR; Montoliu-Gaya L; Serra-Mir G; Villegas S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927795
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Aβ scFv in 3xTg-AD mice.
Montoliu-Gaya L; Güell-Bosch J; Esquerda-Canals G; Roda AR; Serra-Mir G; Lope-Piedrafita S; Sánchez-Quesada JL; Villegas S
Biochem Pharmacol; 2018 Sep; 155():380-392. PubMed ID: 30026023
[TBL] [Abstract][Full Text] [Related]
3. Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease.
Giménez-Llort L; Rivera-Hernández G; Marin-Argany M; Sánchez-Quesada JL; Villegas S
MAbs; 2013; 5(5):665-77. PubMed ID: 23884018
[TBL] [Abstract][Full Text] [Related]
4. Progression of Alzheimer's disease and effect of scFv-h3D6 immunotherapy in the 3xTg-AD mouse model: An in vivo longitudinal study using Magnetic Resonance Imaging and Spectroscopy.
Güell-Bosch J; Lope-Piedrafita S; Esquerda-Canals G; Montoliu-Gaya L; Villegas S
NMR Biomed; 2020 May; 33(5):e4263. PubMed ID: 32067292
[TBL] [Abstract][Full Text] [Related]
5. Treatment with scFv-h3D6 Prevented Neuronal Loss and Improved Spatial Memory in Young 3xTg-AD Mice by Reducing the Intracellular Amyloid-β Burden.
Esquerda-Canals G; Roda AR; Martí-Clúa J; Montoliu-Gaya L; Rivera-Hernández G; Villegas S
J Alzheimers Dis; 2019; 70(4):1069-1091. PubMed ID: 31306135
[TBL] [Abstract][Full Text] [Related]
6. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
[TBL] [Abstract][Full Text] [Related]
7. Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide.
Montoliu-Gaya L; Mulder SD; Herrebout MAC; Baayen JC; Villegas S; Veerhuis R
Mol Cell Neurosci; 2018 Jun; 89():49-59. PubMed ID: 29625180
[TBL] [Abstract][Full Text] [Related]
8. Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid β antibody fragment.
Esquerda-Canals G; Marti J; Rivera-Hernández G; Giménez-Llort L; Villegas S
MAbs; 2013; 5(5):660-4. PubMed ID: 23884149
[TBL] [Abstract][Full Text] [Related]
9. Cognitive Impairment in the 3xTg-AD Mouse Model of Alzheimer's Disease is Affected by Aβ-ImmunoTherapy and Cognitive Stimulation.
Roda AR; Esquerda-Canals G; Martí-Clúa J; Villegas S
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33023109
[TBL] [Abstract][Full Text] [Related]
10. Selective orexin 1 receptor antagonist SB-334867 aggravated cognitive dysfunction in 3xTg-AD mice.
Gao WR; Hu XH; Yu KY; Cai HY; Wang ZJ; Wang L; Wu MN
Behav Brain Res; 2023 Feb; 438():114171. PubMed ID: 36280008
[TBL] [Abstract][Full Text] [Related]
11. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
[TBL] [Abstract][Full Text] [Related]
12. Active full-length DNA Aβ
Rosenberg RN; Fu M; Lambracht-Washington D
Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
15. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
16. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
[TBL] [Abstract][Full Text] [Related]
17. Towards the improvement in stability of an anti-Aβ single-chain variable fragment, scFv-h3D6, as a way to enhance its therapeutic potential.
Montoliu-Gaya L; Murciano-Calles J; Martinez JC; Villegas S
Amyloid; 2017 Sep; 24(3):167-175. PubMed ID: 28699800
[TBL] [Abstract][Full Text] [Related]
18. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.
Winton MJ; Lee EB; Sun E; Wong MM; Leight S; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2011 May; 31(21):7691-9. PubMed ID: 21613482
[TBL] [Abstract][Full Text] [Related]
19. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-β and Tau Pathologies.
Fanet H; Tournissac M; Leclerc M; Caron V; Tremblay C; Vancassel S; Calon F
J Alzheimers Dis; 2021; 79(2):709-727. PubMed ID: 33337360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
